Skip to main content
. 2020 Apr 16;11:208. doi: 10.3389/fendo.2020.00208

Table 1.

Baseline characteristics of patients.

Pattern 1
Age ≥ 40 y
AMH < 1.1
(n = 310)
Pattern 2
Age ≥ 40 y
AMH < 1.1
PS ≤ 3 COCs
(n = 169)
Pattern 3
Age ≥ 40 y
PS ≤ 3 COCs
(n = 52)
Pattern 4
Age < 40 y
AMH < 1.1
PS ≤ 3 COCs
(n = 315)
P-value
Age (years) 41 (40–42)
41.3 ± 1.2
41 (41–42)
41.4 ± 1.1
41 (40–42)
41.3 ± 1.0
36 (33–38)
35.3 ± 3.5
<0.001a
BMI (kg/m2) 24 (22–28)
25.1 ± 4.4
24 (22–28)
24.9 ± 4.3
24 (21–27)
24.2 ± 4.6
24 (22–28)
25.2 ± 4.7
0.483a
Basal FSH 10.1 (8.0–12.8)
10.8 ± 4.0
10.3 (7.7–13.3)
10.8 ± 4.6
9.6 (7.6–11.4)
9.6 ± 3.2
9.8 (7.4–12.4)
10.5 ± 4.4
0.389a
AMH (ng/ml) 0.55 (0.30–0.80)
0.57 ± 0.29
0.47 (0.29–0.78)
0.54 ± 0.28
1.5 (1.3–1.9)
1.7 ± 0.6
0.4 (0.3–0.7)
0.5 ± 0.3
<0.001a
AFC 4 (2–6)
4.6 ± 2.7
4 (2–6)
4.4 ± 2.6
8 (5–12)
8.8 ± 4.2
4 (3–6)
4.6 ± 2.7
<0.001a
PS attempts (n) 1 (0–2) 2 (1–4) 2 (1–4) 2 (1–3) <0.001a

PS, previous stimulation; COC, cumulus-oocyte complex; BMI, body mass index; FSH, follicle stimulating hormone; AMH, antimüllerian hormone; AFC, antral follicle count.

a

Kruskal–Wallis test. Values are mean (SD) and median (IQR).